132 related articles for article (PubMed ID: 31938298)
21. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma.
Cho H; Kim SH; Kim SJ; Chang JH; Yang WI; Suh CO; Cheong JW; Kim YR; Lee JY; Jang JE; Kim Y; Min YH; Kim JS
Ann Hematol; 2017 Jul; 96(7):1163-1173. PubMed ID: 28508176
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
[TBL] [Abstract][Full Text] [Related]
24. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
25. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Lee H; Kim SK; Kim YI; Kim TS; Kang SH; Park WS; Yun T; Eom HS
J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
[TBL] [Abstract][Full Text] [Related]
26. [The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL].
Ohshima K; Miyoshi H; Yamada K
Rinsho Ketsueki; 2018; 59(5):574-587. PubMed ID: 29877249
[TBL] [Abstract][Full Text] [Related]
27. [Clinical characteristics and analysis of prognostic factors of 222 patients diagnosed with Hodgkin's lymphoma].
Hu YF; Huang YH; Luo W; Chen MX; Zhang J; Gou F
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3792-3796. PubMed ID: 31874516
[No Abstract] [Full Text] [Related]
28. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
[TBL] [Abstract][Full Text] [Related]
29. The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis.
Wang C; Li P; Wu S; Lu J; Liu Q; Luo H; Song S
Nucl Med Commun; 2016 Apr; 37(4):338-47. PubMed ID: 26741290
[TBL] [Abstract][Full Text] [Related]
30. High proportions of PD-1
Hollander P; Kamper P; Smedby KE; Enblad G; Ludvigsen M; Mortensen J; Amini RM; Hamilton-Dutoit S; d'Amore F; Molin D; Glimelius I
Blood Adv; 2017 Aug; 1(18):1427-1439. PubMed ID: 29296784
[TBL] [Abstract][Full Text] [Related]
31. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Dann EJ; Bairey O; Bar-Shalom R; Mashiach T; Barzilai E; Kornberg A; Akria L; Tadmor T; Filanovsky K; Abadi U; Kagna O; Ruchlemer R; Abdah-Bortnyak R; Goldschmidt N; Epelbaum R; Horowitz NA; Lavie D; Ben-Yehuda D; Shpilberg O; Paltiel O
Br J Haematol; 2017 Sep; 178(5):709-718. PubMed ID: 28589704
[TBL] [Abstract][Full Text] [Related]
32. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.
Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR
Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
[TBL] [Abstract][Full Text] [Related]
35. Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
Ono T; Azuma K; Kawahara A; Sasada T; Matsuo N; Kakuma T; Kamimura H; Maeda R; Hattori C; On K; Nagata K; Sato F; Chitose SI; Shin B; Aso T; Akiba J; Umeno H
Head Neck; 2018 Sep; 40(9):2007-2019. PubMed ID: 29756253
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
[TBL] [Abstract][Full Text] [Related]
37. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract][Full Text] [Related]
38. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
39. FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma.
Kiyasu J; Aoki R; Tanaka PY; Pracchia LF; Calore EE; Perez NM; Kimura Y; Niino D; Sugita Y; Takayanagi R; Abe Y; Matsuoka M; Ohshima K
Pathol Int; 2012 Feb; 62(2):77-83. PubMed ID: 22243776
[TBL] [Abstract][Full Text] [Related]
40. PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival.
Jimenez O; Mangiaterra T; Colli S; García Lombardi M; Preciado MV; De Matteo E; Chabay P
Front Oncol; 2022; 12():957208. PubMed ID: 35992809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]